• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. The functional and therapeutic potential of epitranscriptomics in breast cancer.

The functional and therapeutic potential of epitranscriptomics in breast cancer.

Details
Publisher DOI
10.1080/17501911.2025.2542113
PubMed ID
40823695
Abstract
Breast cancer (BCa) is one of the most commonly diagnosed malignancies worldwide and is clinically heterogenous. BCa is classified into distinct histopathological and molecular subtypes that inform diagnosis, treatment, and prognosis. Although therapeutic advances, particularly targeted therapies, have improved outcomes, metastatic BCa remains an unmet clinical need. In addition, treatment options remain limited especially for triple negative BCa (TNBC). There is an urgent need to develop novel approaches that can prevent, delay, or reverse disease progression in these patients. The roles of genetic and epigenetic alterations in BCa are well established. Emerging evidence highlights the dysregulation of epitranscriptomic mechanisms involving covalent RNA modifications as a contributing factor in BCa pathogenesis. Notably, recent evidence supports functional crosstalk between epigenetic and epitranscriptomic processes with potential clinical and therapeutic relevance. This review explores key epitranscriptomic RNA modifications, m6A, m6Am, m5C, m7G, and m1A in the context of BCa. The functional consequences of the epitranscriptomic regulators ("writers," "erasers", and "readers") are discussed alongside the accumulating evidence of their contribution to cancer development and progression. This review considers how RNA modifications and their regulators might serve as biomarkers or therapeutic targets and offers new directions for translational research and clinical intervention in BCa.
Date Issued
2025-10
Publication Type
Article
Subject(s)
600 Technology > 630 Agriculture
Subjects
5-methylcytosine
•
N1-methyladenosine
•
N6-methyladenosine
•
N7-methylguanosine
•
RNA methylation
•
RNA therapeutics
•
clinical applications
•
epicapome
Language(s)
en
Author(s)
Thompson, Rachel L
Lothion-Roy, Jennifer
Bellows, Eleanor
Woodcock, Corinne L
Jackson-Oxley, Jorja
Haque, Maria
Varun, Dhruvika
Kumari, Amber A
Alsaleem, Mansour
De Brot, Simone  
Institute of Animal Pathology, Teaching Diagnostics  
Institute of Animal Pathology, Laboratory Cancer Therapy Escape I
Ntekim, Atara
Muyangwa-Semanova, Musalwa
Rakha, Emad
Madhusudan, Srinivasan
Archer, Nathan
Fray, Rupert G
Irshad, Sheeba
Emes, Richard D
Jeyapalan, Jennie N
Rutland, Catrin S
Mongan, Nigel P
Harris, Anna E
Additional Credits
Institute of Animal Pathology  
Institute of Animal Pathology, Laboratory Cancer Therapy Escape I
Department of Infectious Diseases and Pathobiology (DIP)  
Institute of Animal Pathology, Teaching Diagnostics  
Journal
Epigenomics
Publisher
Taylor and Francis Group
ISSN
1750-192X
1750-1911
Access(Rights)
metadata.only
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: 24f0a9 [ 4.09. 8:55]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • BORIS Portal & Open Science
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo
Repository logo COAR Notify